Skip to main content
SpringerLink
Log in

Management of Heart Failure in the Elderly

  • Published:
Heart Failure Reviews Aims and scope Submit manuscript

Abstract

The management of chronic heart failure in elderly patients is often complicated by the presence of multiple comorbid conditions, polypharmacy, psychosocial and financial concerns, and difficulties with adherence to complex medication and dietary regimens. In addition, few patients over 80 years of age have been enrolled in clinical trials, so that the efficacy of current heart failure therapies remains uncertain in this age group. Taken together, these factors contribute to the persistently high hospitalization and mortality rates as well as the poor quality of life associated with chronic heart failure in the elderly.

In this article, nonpharmacologic aspects of care and the pharmacotherapy of systolic heart failure in elderly patients are reviewed. Optimal management requires a systematic approach comprising 5 key elements: coordination of care across disciplines, patient and caregiver education, enhancement of self-management skills, effective followup, and the judicious use of medications. However, it must be recognized that even with “best practice” interventions, the prognosis for established heart failure remains poor. Future research must therefore be directed at developing more effective strategies for the prevention of heart failure in our aging population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Owings MF, Lawrence L. Detailed Diagnoses and Procedures, National Hospital Discharge Survey, 1997. National Center for Health Statistics. Vital and Health Statistics, Series 13, No. 145, 1999.

  2. Gooding J, Jette AM. Hospital readmissions among the elderly. J Am Geriatr Soc 1985;33:595-601.

    Google Scholar 

  3. Rich MW, Freedland KE. Effect of DRGs on three-month readmission rate of geriatric patients with congestive heart failure. Am J Public Health 1988;78:680-682.

    Google Scholar 

  4. Vinson JM, Rich MW, Sperry JC, Shah AS, McNamara T. Early readmission of elderly patients with conges-tive heart failure. J Am Geriatr Soc 1990;38:1290- 1295.

    Google Scholar 

  5. Krumholz HM, Parent EM, Tu N, et al. Readmission after hospitalization for congestive heart failure among Medicare beneficiaries. Arch Intern Med 1997;157:99-104.

    Google Scholar 

  6. Philbin EF, Rocco TA, Lidenmuth NW, Ulrich K, Jenkins PL. Clinical outcomes in heart failure: report from a community hospital-based registry. Am J Med 1999;107:549-555.

    Google Scholar 

  7. Krumholz HM, Wang Y, Parent EM, Mockalis J, Petrillo M, Radford MJ. Quality of care for elderly patients hospitalized with heart failure. Arch Intern Med 1997;157:2242-2247.

    Google Scholar 

  8. Rich MW. Heart failure disease management: A criti-cal review. J Cardiac Failure 1999;5:64-75.

    Google Scholar 

  9. Rich MW, Nease RF. Cost-effectiveness analysis in clinical practice: the case of heart failure. Arch Intern Med 1999;159:1690-1700.

    Google Scholar 

  10. Stewart S, Vandenbroek AJ, Pearson S, Horowitz JD. Prolonged beneficial effects of a home-based interven-tion on unplanned readmissions and mortality among patients with congestive heart failure. Arch Intern Med 1999;159:257-261.

    Google Scholar 

  11. Wagner EH, Austin BT, Von Korff M. Organizing care for patients with chronic illness. Mil Quarterly 1996;74:511-544.

    Google Scholar 

  12. Lorig KR, Sobel DS, Stewart AL, et al. Evidence suggesting that a chronic disease self-management program can improve health status while reducing hospitalization. A randomized trial. Med Care 1999;37:5-14.

    Google Scholar 

  13. Rich MW, Brooks K, Luther P. Temporal trends in pharmacotherapy for congestive heart failure at an academic medical center: 1990-1995. Am Heart J 1998;135:367-372.

    Google Scholar 

  14. Croft JB, Giles WH, Pollard RA, Keenan NL, Casper ML, Anda RF. Heart failure survival among older adults in the United States: a poor prognosis for an emerging epidemic in the Medicare population. Arch Intern Med 1999;159:505-510.

    Google Scholar 

  15. Levenson JW, McCarthy EP, Lynn J, Davis RB, Phil-lips RS. The last six months of life for patients with congestive heart failure. J Am Geriatr Soc 2000;48:S101-S109.

    Google Scholar 

  16. Baker R, Hyg MS, Wu AW, et al. Family satisfaction with end-of-life care in seriously ill hospitalized adults. J Am Geriatr Soc 2000;48:S61-S69.

    Google Scholar 

  17. Consensus Recommendations for the Management of Chronic Heart Failure. Am J Cardiol 1999;83(Suppl 2A):1A-38A.

  18. Heart Failure Society of America Guidelines for Management of Patients with Heart Failure Caused by Left Ventricular Systolic Dysfunction: Pharmacolo-gical Approaches. J Cardiac Failure 1999;5:357-382.

    Google Scholar 

  19. Garg R, Yusuf S, for the Collaborative Group on ACE Inhibitor Trials. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortal-ity and morbidity in patients with heart failure. JAMA 1995;273:1450-1456.

    Google Scholar 

  20. Flather MD, Yusuf S, Køber L, et al. Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. Lancet 2000;355:1575-1581.

    Google Scholar 

  21. Packer M, Poole-Wilson PA, Armstrong PW, et al. Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. Circulation 1999;100:2312-2318.

    Google Scholar 

  22. Pitt B, Segal R, Martinez FA, et al. Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE). Lancet 1997;349:747-752.

    Google Scholar 

  23. Pitt B, Poole-Wilson PA, Segal R, et al. Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomized trial - the Losartan Heart Failure Survival Study ELITE II. Lancet 2000;355:1582-1587.

    Google Scholar 

  24. Cohn JN, Archibald DG, Ziesche S, et al. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study. N Engl J Med 1986;314:1547- 1552.

    Google Scholar 

  25. Cohn JN, Johnson G, Ziesche S, et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 1991;325:303-310.

    Google Scholar 

  26. Packer M, Bristow MR, Cohn JN, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 1996;334:1349- 1355.

    Google Scholar 

  27. CIBIS-II Investigators and Committees. The Cardiac Insufficiency Bisoprolol Study II (CIBIS II): a rando-mized trial. Lancet 1999;353:9-13.

    Google Scholar 

  28. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999;353:2001-2007.

    Google Scholar 

  29. Packer M, Coats AJS, Fowler MB, et al. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 2001;344:1651-1658.

    Google Scholar 

  30. The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 1997;336:525-533.

    Google Scholar 

  31. Rich MW, McSherry F, Williford WO, Yusuf S, for the Digitalis Investigation Group. Effect of age on mortal-ity, hospitalizations, and response to digoxin in patients with heart failure: The DIG Study. J Am Coll Cardiol 2001;38:806-813.

    Google Scholar 

  32. Ware JA, Snow E, Luchi JM, et al. Effect of digoxin on ejection fraction in elderly patients with congestive heart failure. J Am Geriatr Soc 1984;32:631-635.

    Google Scholar 

  33. Slatton ML, Irani WN, Hall SA, et al. Does digoxin provide additional hemodynamic and autonomic bene-fit at higher doses in patients with mild to moderate 96 Rich.heart failure and normal sinus rhythm? J Am Coll Cardiol 1997;29:1206-1213.

    Google Scholar 

  34. Channer KS, McLean KA, Lawson-Matthew P, et al. Combination diuretic treatment in severe heart failure: A randomised controlled trial. Br Heart J 1994;71:146-150.

    Google Scholar 

  35. Pitt B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 1999;341:709-717.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Washington University School of Medicine, St. Louis, MO

    Michael W. Rich MD (Associate Professor of Medicine)

Authors
  1. Michael W. Rich MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rich, M.W. Management of Heart Failure in the Elderly. Heart Fail Rev 7, 89–97 (2002). https://doi.org/10.1023/A:1013706023974

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1013706023974

Search

Navigation